Algernon Pharmaceuticalsinc (AGN.CN)
0.0900 unch (unch) 03/20/25 [CNSX]
0.0850 x 10,000 0.1000 x 10,000
Realtime by (Cboe BZX)
0.0850 x 10,000 0.1000 x 10,000
Realtime - - (-) -
for Thu, Mar 20th, 2025
Fiscal Year End Date: 08/31
(Values in thousands)
08-2024 | 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 596 | 125 | 1,409 | 2,411 | 6,121 |
Receivables | 16 | 96 | 666 | 2,295 | 1,229 |
TOTAL | $739 | $340 | $2,827 | $4,909 | $7,738 |
Non-Current Assets | |||||
Intangibles | 3,177 | 3,796 | 5,256 | 5,171 | 5,028 |
Other Non-Current Assets | 29 | 58 | 58 | 58 | 58 |
TOTAL | $3,205 | $3,854 | $5,314 | $5,228 | $5,086 |
Total Assets | $3,944 | $4,194 | $8,141 | $10,138 | $12,824 |
Liabilities | |||||
Current Liabilities | |||||
TOTAL | $1,775 | $2,720 | $2,516 | $1,022 | $607 |
Non-Current Liabilities | |||||
TOTAL | $0 | $0 | $0 | $0 | $0 |
Total Liabilities | $1,775 | $2,720 | $2,516 | $1,022 | $607 |
Shareholders' Equity | |||||
Common Shares | 29,555 | 28,150 | 27,115 | 25,850 | 21,344 |
Retained earnings | -30,756 | -30,792 | -25,187 | -23,546 | -17,463 |
Other shareholders' equity | 3,369 | 4,116 | 3,696 | 6,812 | 8,337 |
TOTAL | $2,169 | $1,474 | $5,625 | $9,115 | $12,217 |
Total Liabilities And Equity | $3,944 | $4,194 | $8,141 | $10,138 | $12,824 |